ISA PHARMACEUTICALS (IDFF)
The status, timeline and source of this project. A free account opens every field.
Source: European Investment Bank (EIB)
The project supports the Company's research and development investments to complete the late stage development (clinical, regulatory, and manufacturing) of ISA101b (a synthetic long peptide (SLP) targeting HPV) in two HPV-induced therapeutic areas i.e. cervical and head and neck cancer.
- Status
- Prospective
- Sector
- Manufacturing (Industrial), Hospital, Hotel, Government
- Location
- Netherlands
- Updated
- 19 Nov 2026
- Source
- European Investment Bank (EIB)
ConstructChat
Ask ConstructChat about ISA PHARMACEUTICALS (IDFF)
Pick a question to edit it, or write your own.
First answer free · no account
Project Information FAQ
Project Information
Participants
Sponsoring Agency |
Status
Original status | financed |
Taiyo status | Prospective |
Taiyo last update | 2026-11-19 |
Contact
| Not available for this record. |
Description
Description | The project supports the Company's research and development investments to complete the late stage development (clinical, regulatory, and manufacturing) of ISA101b (a synthetic long peptide (SLP) targeting HPV) in two HPV-induced therapeutic areas i.e. cervical and head and neck cancer. |
Original sector | Services |
Budget |
Location
Country | Netherlands |
Source
Source reliability | High |
Source | European Investment Bank (EIB) |
URL |
More Details
Record type | Project |
Sector | Manufacturing (Industrial), Hospital, Hotel, Government |
Article published date | 2023-05-08 |
Research
Free account
View all details
You are reading the public part. A free account opens the rest:
- Every detail on this project
- News and media coverage
- Technical research
Free account · no card · lands you back on this project
